monocrotaline has been researched along with Weight Gain in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eguchi, M; Ikeda, S; Kawano, H; Koide, Y; Kusumoto, S; Maemura, K; Sato, D | 1 |
| Auzani, JA; Belló-Klein, A; Khaper, N; Picoral, M; Silva, LF; Souza-Rabbo, MP | 1 |
| Pan, LC; Segall, HJ; Wilson, DW | 1 |
| Clozel, JP; Clozel, M; Hess, P | 1 |
| Gewitz, MH; Gloster, ES; Mathew, R; Sundararajan, T; Thompson, CI; Zeballos, GA | 1 |
| Block, N; Brock, TA; Chen, SJ; Chen, YF; Dixon, RA; Munsch, CL; Sherwood, SJ; Tilton, RG; Wu, C | 1 |
| Altura, BM; Altura, BT; Mathew, R | 1 |
7 other study(ies) available for monocrotaline and Weight Gain
| Article | Year |
|---|---|
Adipose-derived regenerative cell therapy inhibits the progression of monocrotaline-induced pulmonary hypertension in rats.
Topics: Adipose Tissue; Animals; Disease Progression; Gene Expression Profiling; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Rats, Wistar; Regenerative Medicine; RNA, Messenger; Stem Cell Transplantation; Survival Analysis; Vascular Remodeling; Weight Gain | 2014 |
Effects of a chronic exercise training protocol on oxidative stress and right ventricular hypertrophy in monocrotaline-treated rats.
Topics: Animals; Catalase; Glutathione Transferase; Hypertrophy, Right Ventricular; Male; Monocrotaline; Oxidative Stress; Physical Conditioning, Animal; Pulmonary Heart Disease; Rats; Rats, Wistar; Superoxide Dismutase; Weight Gain | 2008 |
Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular disease.
Topics: Animals; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Pulmonary Artery; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Species Specificity; Weight Gain | 1993 |
Telemetry monitoring of pulmonary arterial pressure in freely moving rats.
Topics: Animals; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Bosentan; Cardiac Catheterization; Hypertension, Pulmonary; Male; Monocrotaline; Motor Activity; Organ Size; Pulmonary Artery; Rats; Rats, Wistar; Sulfonamides; Telemetry; Weight Gain | 1996 |
Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension.
Topics: Animals; Arterioles; Blood Pressure; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Injections, Subcutaneous; Male; Molsidomine; Monocrotaline; Nitrates; Nitric Oxide; Poisons; Pulmonary Artery; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Vasodilator Agents; Weight Gain | 1997 |
Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist.
Topics: Animals; Cardiomegaly; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Hypertension, Pulmonary; Hypertrophy; Hypoxia; Isoxazoles; Male; Monocrotaline; Oxygen; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Thiophenes; Vasoconstriction; Weight Gain | 2000 |
Strain differences in pulmonary hypertensive response to monocrotaline alkaloid and the beneficial effect of oral magnesium treatment.
Topics: Animals; Cardiomegaly; Hypertension, Pulmonary; Magnesium; Male; Monocrotaline; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Species Specificity; Weight Gain | 1989 |